Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Auro Laboratories Ltd

NSE: AUROLAB · BSE: 530233 · Pharmaceuticals & Biotechnology · 15 announcements

Auro Laboratories Ltd news stories on ALFA NewsRead the news →
Share price
₹232.55
Market cap
₹144.9 Cr
Revenue (annual)
₹32.61 Cr
Net profit (annual)
₹3.53 Cr
P/E (TTM)
30.9×Sector 47.3×
Promoter holding
52.40%+0.22% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

19:15 IST BSE
Regulatory Approval

Auro Laboratories Regulatory Approval

Auro Laboratories Limited received an 'Attestation of Inspection' from the EDQM for its MIDC Tarapur facility. The certification confirms compliance with EU Good Manufacturing Practice (GMP) standards for Metformin Hydrochloride. This regulatory milestone validates the facility's quality standards for European market requirements.

19:10 IST BSE
Regulatory Approval

Auro Laboratories Regulatory Approval

Auro Laboratories Ltd has received a Certificate of GMP Compliance (No. 26-0002) from Swissmedic for its manufacturing facility in Tarapur, Maharashtra. The certification confirms compliance with GMP requirements under the EU-Switzerland Mutual Recognition Agreement, validating the plant's quality standards for therapeutic products.